Skip to main content
. 2012 Jul 29;16(8):1866–1877. doi: 10.1111/j.1582-4934.2011.01482.x

Fig 4.

Fig 4

Schematic representation of the working mechanism for the pharmacological intervention in CCR5 transcription. Zebularine inhibits DNMTs, whereas MS275 inhibits HDACs. DZNep is a more general KMTase inhibitor [43].